On March 31, 2026, Callan JMB Inc. (NASDAQ: CJMB) announced its financial results for the year ended December 31, 2025, revealing a decline in revenue and an increase in operational losses. The company reported revenues of $5.7 million, down from $6.6 million in 2024, attributed to decreased demand for emergency preparedness services from various state and local governments. The cost of revenues also decreased to $3.6 million from $4 million, reflecting the reduced demand. However, the company's gross profit fell to $2.1 million from $2.6 million in the previous year. Notably, selling, general, and administrative expenses surged to $8.6 million, up from $4.8 million, primarily due to increased professional fees related to the company's initial public offering and other operational costs. Consequently, Callan JMB reported a loss from operations of $7 million, compared to a loss of $2.3 million in 2024. The company ended the year with cash and cash equivalents of $2.1 million. Despite the challenges, CEO Wayne Williams emphasized the company's commitment to strengthening its core infrastructure and pursuing strategic growth initiatives in high-velocity sectors such as healthcare and food logistics. The company aims to enhance its emergency preparedness operations while expanding its pharmaceutical logistics and specialty distribution capabilities. Callan JMB's focus on building resilient supply chains and maintaining exceptional service levels is expected to drive future growth, even as it navigates current operational challenges.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.